Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

NCT: NCT05712161 · ACTIVE_NOT_RECRUITING

NCT IDNCT05712161
StatusACTIVE_NOT_RECRUITING
Start Date2023-08-07
Completion2033-12

Brief Summary

To evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis.

Frequently Asked Questions

What is Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study?

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study is a clinical trial registered under NCT05712161. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05712161?

The current status of NCT05712161 (Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study) is: ACTIVE_NOT_RECRUITING.

When did Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study start?

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study started on 2023-08-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑